These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6754328)

  • 21. [Fibrin-stabilizing factor and its significance in the surgical treatment of patients with obstructive jaundice].
    Myslovatyĭ BS; Gorbovitskiĭ EB; Deputovich SA; Dzheĭranov FD
    Vestn Khir Im I I Grek; 1989 Mar; 142(3):79-81. PubMed ID: 2750013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation factor XIII, endothelial damage and systemic sclerosis.
    Marzano AV; Federici AB; Gasparini G; Mannucci PM; Caputo R; Berti E
    Eur J Dermatol; 2000; 10(1):14-7. PubMed ID: 10694291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Substitution of factor XIII concentrate in treatment refractory ulcerative colitis. A prospective pilot study].
    Lorenz R; Born P; Classen M
    Med Klin (Munich); 1994 Oct; 89(10):534-7. PubMed ID: 7741858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor XIII deficiency as the cause of postoperative hemorrhage].
    Quiel V
    Zentralbl Gynakol; 1993; 115(12):562-4. PubMed ID: 8147170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
    Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
    Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lessening the impairment of wound healing by pre-or postoperative quantitative factor-XIII substitution (author's transl)].
    Baer J; Bauknecht J; Stangl T; Häring R
    Zentralbl Chir; 1980; 105(10):642-51. PubMed ID: 7456815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: a crossover randomised study.
    Brackmann HH; Egbring R; Ferster A; Fondu P; Girardel JM; Kreuz W; Masure R; Miloszewski K; Stibbe J; Zimmermann R
    Thromb Haemost; 1995 Aug; 74(2):622-5. PubMed ID: 8584996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias].
    Egbring R; Schmidt W; Havemann K
    Verh Dtsch Ges Inn Med; 1973; 79():1351-4. PubMed ID: 4790179
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
    Nugent DJ
    Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Substitution treatment of factor XIII deficiency with a new factor XIII concentrate].
    Trobisch H; Egbring R
    Dtsch Med Wochenschr; 1972 Mar; 97(13):499-502. PubMed ID: 5011493
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
    Daly HM; Haddon ME
    Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.
    Visich JE; Zuckerman LA; Butine MD; Gunewardena KA; Wild R; Morton KM; Reynolds TC
    Thromb Haemost; 2005 Oct; 94(4):802-7. PubMed ID: 16270634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
    Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
    Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A contribution to the pathology of acquired plasma factor XIII deficiency.
    Ballerini G; Guerra S; Rodeghiero F; Castaman G
    Semin Thromb Hemost; 1985 Oct; 11(4):357-61. PubMed ID: 4071061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance, diagnosis and substitution in acquired factor XIII deficiency in the postoperative course].
    Thies HA; Kuder E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):201-6. PubMed ID: 50985
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy.
    Szántó T; Salmela B; Mäkipernaa A; Armstrong E; Lassila R
    Haemophilia; 2008 Jan; 14(1):163-5. PubMed ID: 17961171
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factor XIII deficiency in various patients with acute leukemia].
    Egbring R; Havemann K
    Verh Dtsch Ges Inn Med; 1971; 77():97-100. PubMed ID: 5155938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.